retatrutide triple agonist clinical trial Reta data & dosing โ a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health โ targeting GLP-1, GIP ๐จ Today, retatrutide, the GIP/GLP-1/glucagon
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 5 - Aug 10









:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)



.png)














